1 report

  • 6. APPENDIX 1: TABULATED DATA
  • 14. CONCLUSION

DPP## INHIBITORS BLOCK THE ACTIVITY OF GLP-## AND GIP.

  • Antidiabetics
  • Diabetes
  • Gliptins
  • Pharmaceutical
  • Novo Nordisk Group